Extracellular vesicles (EVs) have become an important component of liquid biopsy technologies and a valuable source of biomarkers for early disease detection. However, current EV isolation and enrichment methods still face significant limitations, including low efficiency, insufficient purity, and lack of standardized workflows, which restrict broader clinical and research applications. These challenges are particularly critical in early cancer screening and in the detection of major infectious diseases involving very low-level pathogens. Efficient and high-purity enrichment of EVs and co-isolated viral particles is essential for biomarker discovery and for improving analytical sensitivity.
IMPMM has developed advanced methods for the co-isolation of EVs and viruses from complex biological samples, significantly improving enrichment efficiency and target purity. These technologies provide reliable analytical support for non-invasive cancer diagnostics and infectious disease research.
